The Trump administration has lifted some regulatory requirements for coronavirus tests, which officials say will allow more tests to enter the market.

The regulatory change announced this week will increase flexibility to make coronavirus tests developed by commercial labs such as Quest Diagnostics and LabCorp more accessible to the public. The legal team at Health and Human Services decided to scrap a rule that the FDA issued when the public health emergency began, which would have required labs to submit tests for the lengthy approval process before making them available for public use.